Ind-Swift Laboratories Balance Sheet
- Market cap
- ₹3,073 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹254.77 – ₹477.70
As of FY25, Ind-Swift Laboratories had total assets of ₹1,997 crore and borrowings of ₹369 crore, against shareholders' equity of ₹1,503 crore — a debt-to-equity ratio of 0.35.
Ind-Swift Laboratories balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 1,383 |
| Borrowings | 369 |
| Other liabilities | 246 |
| Total liabilities | 1,997 |
| Fixed assets | 1,075 |
| Capital work in progress | 45 |
| Investments | 461 |
| Other assets | 461 |
| Total assets | 1,997 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹124.16
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Ind-Swift Laboratories balance sheet — frequently asked questions
What is the total debt of Ind-Swift Laboratories?
Ind-Swift Laboratories reported borrowings of ₹369 crore as of FY25.
What is Ind-Swift Laboratories' debt-to-equity ratio?
Based on the FY25 balance sheet, Ind-Swift Laboratories' debt-to-equity ratio is 0.35 — borrowings of ₹369 crore against equity capital and reserves of ₹1,503 crore.
What are Ind-Swift Laboratories' total assets?
Ind-Swift Laboratories' total assets were ₹1,997 crore as of FY25, including fixed assets of ₹1,075 crore and investments of ₹461 crore.
What is the book value per share of Ind-Swift Laboratories?
The book value per share of Ind-Swift Laboratories is ₹124.16, based on the latest reported balance sheet.
Same Data For Peers
Trade Ind-Swift Laboratories With ATS
Track INDSWFTLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.